Notice of Intent to Sole Source
SAM.GOV Due: June 16, 2025 at 07:00 PM UTC
In-Active Special Notice NONE Source Url

Summary

The Food and Drug Administration (FDA) has issued a Notice of Intent to Sole Source for the purchase of human induced pluripotent stem cells (hiPSC Cells). The FDA intends to award a Firm Fixed Price contract to Fujifilm Irvine Scientific, Inc., as they are deemed the only responsible source capable of fulfilling the agency's requirements. This opportunity is not open for competitive proposals; however, other parties that believe they can meet the specified requirements are invited to submit a written capability statement. The contract is expected to be awarded within approximately ten days following the notice, contingent upon the government's assessment of the capability statements received. Contractors with expertise in biopharmaceuticals, particularly those specializing in stem cell technology, are encouraged to consider this opportunity.
Entities
HAHSDO
Department of Health and Human Services
NAICS
541714
Set Aside
NONE : No Set aside used
Place of Performance
Silver Spring , Maryland 20993
Point of Contact
Full Name Email Phone Type
Rodney D. Aytch [email protected] 2404027514 primary
Attachments
  • SOW_042825.doc
  • Solicitation+-+Notice+of+Intent+to+SS.pdf